Manufacturer
163 recalls in our database name Dr. Reddy's Laboratories, Inc. as the manufacturing or recalling firm.
Of the 163 recalls from Dr. Reddy's Laboratories, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 30 (18%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Dr. Reddy's Laboratories is recalling Olanzapine tablets because an impurity exceeded specification limits during stability testing.
Dr. Reddy's Laboratories is recalling Flucanazole tablets because they failed dissolution and stability specifications.
Dr. Reddy's is recalling Flucanazole tablets that failed dissolution and stability specifications. Patients should stop using the affected lots and consult their healthcare provider.
Dr. Reddy's Laboratories is recalling Flucanazole 150 mg tablets because they failed dissolution specifications and 18-month stability testing.
Dr. Reddy's Laboratories is recalling Flucanazole 200 mg tablets nationwide due to failed dissolution specifications and stability issues.
Dr. Reddy's Laboratories is recalling ZENATANE (isotretinoin) 20 mg capsules because they failed to meet dissolution specifications. The recall covers 3,858 prescription packs distributed nationwide.
Dr. Reddy's Laboratories is recalling specific lots of Sirolimus tablets because they failed impurity specifications for secorapamycin.
Dr. Reddy's is recalling CVS pharmacy Acid Controller tablets because stability testing revealed an out-of-specification impurity.
Dr. Reddy's Laboratories is recalling 50,280 bottles of Ondansetron Tablets USP, 4 mg, due to failed impurities and degradation specifications.
Dr. Reddy's Laboratories is recalling 3,342 vials of Zoledronic Acid Injection due to defective seals that may compromise sterility.
Dr. Reddy's Laboratories is recalling Paricalcitol capsules due to reports of breakage and leakage. The recall covers 4,383 bottles distributed nationwide.
Dr. Reddy's Laboratories is recalling 11,123 bottles of Paricalcitol capsules nationwide because the capsules have broken and leaked.
Dr. Reddy's Laboratories is recalling 9,155 bottles of Paricalcitol capsules nationwide due to reports of breakage and leakage.
Dr. Reddy's Laboratories is recalling Amlodipine Besylate and Atorvastatin Calcium tablets because the atorvastatin component is subpotent.
Dr. Reddy's Laboratories is recalling 1,056 bottles of Amlodipine Besylate and Atorvastatin Calcium tablets because the atorvastatin component is subpotent.
Dr. Reddy's Laboratories is recalling 984 bottles of Amlodipine Besylate and Atorvastatin Calcium tablets because the atorvastatin component is subpotent.
Dr. Reddy's Laboratories is recalling 576 bottles of Amlodipine Besylate and Atorvastatin Calcium tablets because the atorvastatin component is subpotent.
Dr. Reddy's is recalling specific lots of Amlodipine Besylate and Atorvastatin Calcium tablets because they contain subpotent atorvastatin.
Dr. Reddy's is recalling Amlodipine Besylate and Atorvastatin Calcium tablets because the atorvastatin component was found to be subpotent.
Dr. Reddy's Laboratories is recalling specific lots of Amlodipine Besylate and Atorvastatin Calcium tablets because they contain subpotent atorvastatin.
Dr. Reddy's Laboratories is recalling Rivastigmine Tartrate capsules because they failed to meet dissolution specifications.
Dr. Reddy's is voluntarily recalling specific lots of Amlodipine and Atorvastatin tablets because they contain less active ingredient than labeled.
Dr. Reddy's Laboratories is recalling 5,160 bottles of Divalproex Sodium Extended-Release Tablets because they failed to meet dissolution specifications.
Dr. Reddy's Laboratories is recalling Divalproex Sodium Extended-Release Tablets because they failed to meet dissolution specifications at the 9-hour time point.
Dr. Reddy's Laboratories is recalling specific lots of Amlodipine Besylate and Atorvastatin Calcium tablets because they contain less than the labeled amount of active ingredients.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Dr Reddy's Laboratories (Switzerland)
Source: Wikidata (Q30343911), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.